COVID-19普通病房患者系统性双功超声筛查静脉血栓及5天随访
本研究对72例入住普通病房的COVID-19患者于入院当天(D0)和第5天(D5)行下肢静脉双功超声筛查。D0急性深静脉血栓(DVT)检出率为9.75%,D5新增5例(15.6%)。D-二聚体水平与急性DVT显著相关,而C反应蛋白和体重指数无显著关联。
要点
- COVID-19普通病房患者DVT发生率较高,D0为9.75%,D5新增15.6%。
- D-二聚体水平与急性DVT显著相关(P < .01)。
- 即使预防性使用低分子肝素,D5仍新发3例远端和2例近端DVT。
核心结论
- COVID-19普通病房患者静脉血栓事件频率高,支持进行双功超声筛查。
研究设计与样本
- 前瞻性研究纳入72例COVID-19普通病房患者,平均年龄65 ± 12.3岁,其中女性28例。
- 入院时启动低分子肝素预防性抗凝,于D0和D5行下肢完整静脉双功超声检查。
主要发现
- D0双功超声显示7例(9.75%)急性DVT。
- 12例(16.65%)行肺动脉CT血管造影,其中3例(25%)有急性肺栓塞。
- D0急性DVT与D-二聚体水平显著相关(1536 ± 2347 vs 9652 ± 10,205 ng/mL,P < .01)。
- D0急性DVT与C反应蛋白(101 ± 98.6 vs 67.6 ± 58.4 mg/L,P = .43)和体重指数(27.7 ± 5.04 vs 28.1 ± 2.65 kg/m2,P = .54)无显著关联。
- D5仅32例完成双功超声,新发5例(15.6%)急性DVT,其中3例远端、2例近端。
临床怎么用
- 对COVID-19普通病房患者应考虑系统性下肢静脉双功超声筛查,尤其D-二聚体显著升高者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: COVID-19 patients may develop coagulopathy, which is associated with poor prognosis and high risk of thrombosis. The main objective of this work was to evaluate the prevalence of deep venous thrombosis of lower limbs (DVT) through ultrasonography in patients infected with COVID-19 admitted to conventional units at our hospital with 5 days of monitoring. The secondary objective was to determine if D-dimer levels, body mass index, and C-reactive protein were associated with DVT. METHODS: A total of 72 patients, with a mean age of 65 ± 12.3 years, infected with COVID-19 were admitted to three conventional units at our institution; 28 patients were women. A COVID-19 diagnosis was made by a transcriptase polymerase chain reaction by means of nasopharyngeal swab or by chest computer tomography without iodine contrast media. Demographics, comorbidities, and laboratory parameters were collected. A preventive anticoagulation treatment was established on admission with low-molecular-weight heparin. A complete venous duplex ultrasound (DU) test of lower limbs was performed on day (D) 0 and D5. A pulmonary computer tomography angiogram with iodine contrast media was required when pulmonary embolism was suspected. RESULTS: On D0, the DU showed acute DVT in seven patients (9.75%). A pulmonary computer tomography angiogram was performed in 12 patients (16.65%), 3 (25%) of whom had an acute pulmonary embolism. On D0, acute DVT was not significantly associated with C-reactive protein (mean 101 ± 98.6 in the group without DVT vs 67.6 ± 58.4 mg/L, P = .43) or body mass index (27.7 ± 5.04 vs 28.1 ± 2.65 kg/m2, P = .54). However, we found a significant association between acute DVT and D-dimer levels (1536 ± 2347 vs 9652 ± 10,205 ng/mL, P < .01). Among the patients included on D0, only 32 had a DU on D5. Forty of them (55.55%) were not examined for the following reasons: 7 (9.7%) were previously diagnosed with venous thromboembolism on D0 and therefore were excluded on D5, 8 (11%) were transferred to the intensive care unit, 10 (14%) were discharged from the hospital, 5 (7%) died, and 10 (13.9%) were excluded because of technical issues. On D5, five (15.6%) patients had acute DVT in addition to those found on D0; three were distal and two proximal despite preventive anticoagulation with low-molecular-weight heparin. CONCLUSIONS: Hospitalized non-intensive care unit patients with COVID-19 pneumonia have a high frequency of venous thrombotic events justifying screening with DU.
引用
- Hamadé A, Jambert L, Tousch J, et al. Systematic duplex ultrasound screening in conventional units for COVID-19 patients with follow-up of 5 days. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33278644. doi:10.1016/j.jvsv.2020.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。